Gene transfer of alpha interferon into hematopoietic stem cells

Leukemia Research

Volumn 22, Issue 2, 1998, Pages 119-124

  Ahmed, T ^a   Lutton, J D ^a   Feldman, E ^a   Tani, K ^b   Asano, S ^b   Abraham, N G ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

interferon; Gene transfer; Stem cells

Indexed keywords

ALPHA INTERFERON; CD34 ANTIGEN;

ADENOVIRUS; ARTICLE; CHRONIC MYELOID LEUKEMIA; FLOW CYTOMETRY; GENE CONSTRUCT; GENE TRANSFER; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; NORMAL HUMAN; PRIORITY JOURNAL;

ADENOVIRIDAE; ANTIGENS, CD34; CYTOMEGALOVIRUS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; HUMANS;

EID: 0032007218     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(97)00133-1     Document Type: Article

References (30)

1. 1. Italian Cooperative Study Group on Chronic Myeloid Leukemia, Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia, N. Engl. J. Med., 1994, 30, 820.
2. 2. Broxmeyer, H. E., Lu, E., Platzer, E., Feit, C., Juliano, L. and Rubin, B. Y., Comparative analyses of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte macrophage (CFU-GM) progenitor cells. J. Immunol., 1983, 131, 1330.
3. 3. Geissler, D., Gastl, G., Aulitzky, W., Tilg, H., Gaggl, S., Konwalinka, G. and Huber, C., Recombinant interferon-alpha-2C in chronic myelogenous leukemia: relationship of sensitivity of committed haematopoietic precursor cells in vitro (BFU-E, CFU-GM, CFU-Meg) and clinical response. Leukemia Res., 1990, 14, 629.
4. 4. Upadhyaya, G., Guba, S. C., Sih, S. A., Feinberg, A. P., Talpaz, M., Kantarjian, H. M., Deisseroth, A. B. and Emerson, S. G., Interferon-alpha restores the deficient expression of the cytoadhesion molecule lymphocyte function antigen-3 by chronic myelogenous leukemia progenitor cells. J. Clin. Invest., 1991, 88, 2131.
5. 5. Dowding, C., Guo, A. P., Osterholz, J., Sickowski, M., Goldman, J. and Gordon, M., Interferon-alpha overrides the deficient adhesion of chronic myelogenous leukemia primitive progenitor cells to bone marrow stromal cells. Blood, 1991, 78, 499.
6. 6. Bathia, R., McGlave, P. and Verfaillie, C. M., Treatment of marrow stroma with interferon-α restores normal b1 integrin-dependent adhesion of chronic myelogenous leukemia hematopoietic progenitors. Role of MIP-1a. J. Clin. Invest., 1995, 96, 931.
7. 7. Aman, J. M., Keller, U., Derigs, G., Mohammadzadeh, M., Huber, C. and Peschel, C., Regulation of cytokine expression by interferon alpha in human bone marrow stroma cells: inhibition of hematopoietic growth factors and induction of IL-1 receptor antagonist. Blood, 1994, 84, 4142.
8. 8. Bathia, R., McGlave, P. B. and Verfaillie, C. M., Interferon-α treatment of marrow stroma results in enhanced adhesion of chronic myelogenous leukemia progenitors via mechanism involving MIP-1a and TGF-b. Exp. Hematol, 1994, 22, 797a(abstr).
9. 9. Zoumbos, N., Gascon, P. and Young, N. S., The induction of lymphocytes in normal and suppressed hematopoiesis. Blut, 1984, 48, 1.
10. 10. Emerson, S. B. and Antin, J. H., Bone marrow progenitor cells induce a regulatory autologous proliferative T lymphocyte response. J. Immunol., 1989, 142, 766.
11. 11. Cashmann, J. D., Eaves, A. C., Raines, E. W., Ross, R. and Eaves, C. J., Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer. Blood, 1991, 78, 110.
12. 12. Hanabuchi, S., Koyanagi, M., Kawasaki, A., Shinohara, N., Matsuzawa, A., Nishimura, Y., Kobayashi, Y., Yonehara, Y., Yagita, H. and Okumura, K., Fas and its ligand is a general mechanism of T-cell-mediated cytotoxicity. Proc. Natl. Acad. Sci. USA, 1994, 91, 4930.
13. 13. Owen-Schaub, L. B., Meterissian, S. and Ford, R. J., Fas/ APO-1 expression and function on malignant cells of hematologic and non-hematologic origin. J. Immunother., 1993, 14, 234.
14. 14. Robertson, M. J., Manley, T. J., Pichert, G., Cameron, C., Cochran, K. J., Levin, H. and Ritz, J., Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells. Leukemia Lymphoma, 1994, 17, 51.
15. 15. Chertkov, J. L., Jiang, S., Lutton, J. D., Harrison, J., Levere, R. D., Tiefenthaler, M. and Abraham, N. G., The hematopoietic stromal microenvironment promotes retrovirus-mediated gene transfer into hematopoietic stem cells. Stem Cells, 1993, 11, 218.
16. 16. Abraham, N. G., da Silva, J.-L., Lavrovsky, Y., Stoltz, R. A., Kappas, A., Dunn, M. W. and Schwartzman, M. L., Adenovirus-mediated heme oxygenase-1 gene transfer into rabbit ocular tissues. Invest, Ophthalmol, Vis. Sci., 1995, 36, 2202.
17. 17. Ohwada, A., Rafii, S., Moore, M. A. S. and Crystal, R. G., In vivo adenovirus vector-mediated transfer of the human thrombopoietin cDNA maintains platelet levels during radiation-and chemotherapy-induced bone marrow suppression. Blood, 1996, 88, 778.
18. 18. Dunbar, C. E., Fox, M., O'Shaughnessey, J., Doren, D., Emmons, R. V. B., Soma, T., Yu, J. M., Carter, C., Seller, S., Hines, K., Cowan, K., Young, N. S. and Nienhuis, A. W., Gene Transfer to Hematopoietic Progenitor and Stem Cells: Progress and Problems. Hematology Branch, National Heart, Lung and Blood Institute, National Institute, National Institutes of Health, Bethesda, MD, USA.
19. 19. Mulligan, R. C., The basic science of gene therapy. Science, 1994, 260, 926.
20. 20. Hanania, E. G., Kavanagh, J., Hortogagyi, G., Giles, R. E., Champlin, R. and Deisseroth, A. B., Recent advances in the application of gene therapy to human disease. Am. J. Med., 1995, 99, 537.
21. 21. Christal, R. G., Mcelvaney, N. G., Rosenfeld, M. A., Chu, C., Mastrangeli, A., Hay, J. G., Brody, S. L., Jaffe, H., Eissa, N. T. and Danel, C., Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nature Genet., 1994, 8, 42.
22. 22. Brandt, J. E., Baird, N., Lu, L., Srour, E. and Hoffman, R., Characterization of a human hematopoietic progenitor cell capable of forming blast cell containing colonies in vitro. J. Clin Invest., 1988, 82, 1017.
23. 23. Verfaillie, C. and McGlave, P. B., Leukemia inhibitory factor/human interleukin for DA cells: a growth factor that stimulates the in vitro development of multipotential human hemopoietic progenitors. Blood, 1991, 77, 263.
24. 24. Verfaille, C., Blakholmer, K. and McGlave, P., Purified primitive human hematopoietic progenitors with long term in vitro repopulating capacity adhere selectively to irradiated bone marrow stroma. J. Exp. Med., 1990, 179, 509.
25. + marrow cells engraft lethally irradiated baboons. J. Clin. Invest., 1988, 81, 951.
26. 26. Verfaillie, C. M., Miller, W. J., Boylan, K. and McGlave, P. B., Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of DR antigen expression. Blood, 1992, 79, 1003.
27. 27. Leemhuis, T., Liebowitz, D., Cox, G., Silver, R., Srour, E. F., Tricot, G. and Hoffman, R., Identification of BCR/ ABL-negative primitive hematopoietic progenitor cells within chronic myeloid leukemia marrow. Blood, 1993, 81, 801.
28. BCR-ABL expression and inhibit the proliferation of BCR/ABL-containing cell lines. Blood, 1993, 81, 502.
29. 29. Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A. and Struhl, K., Current Protocols in Molecular Biology. John Wiley & Sons, New York, 1987.
30. 30. Talpaz, M., Kantarjiian, H., Kurzrock, R., Trujillo, M. J. and Gutterman, J. U., Interferon-alpha produced sustained cytogenetic responses in chronic myelogenous leukemia. Ann. Intern. Med., 1991, 114, 532.